Therapeutic applications of cell membrane-coated nanoparticles in oral diseases: Opportunities, challenges, and future perspectives

Abstract

Nanotechnology holds great promise for disease therapy; however, the therapeutic efficacy of nanoparticles (NPs) is often limited by rapid recognition and clearance by the immune system. Recent studies have demonstrated that coating NPs with natural cell membranes imparts physicochemical properties closely resembling those of the source cells. This biomimetic coating also transfers key biological components, such as surface proteins and antigens, onto the NPs, endowing them with unique functionalities, including immune evasion, targeted delivery, and modulation of the immune microenvironment. These attributes underscore the significant potential of cell membrane-coated nanoparticles (CNPs) for a wide range of biomedical applications, including those in oral healthcare. Oral diseases are among the most prevalent non-communicable conditions globally, significantly affecting the quality of daily life and posing major public health challenges. As an emerging class of biological carriers, CNPs have been effectively utilized in the diagnosis and treatment of various oral diseases, including head and neck tumors and periodontitis. Owing to their high biocompatibility, targeted delivery capabilities, and extended circulation time, CNPs exhibit excellent therapeutic potential and offer a novel approach that complements conventional oral treatments. This review provides a comprehensive overview of the definition, classification, and fabrication methodologies of CNPs. It highlights recent advances in their diverse applications, with a particular focus on oral healthcare, critically examines current challenges, and concludes with perspectives to inform and guide future research.

Keywords

Cell membrane coating / Nanoparticles / Immune regulation / Oral diseases / Therapeutics / Diagnostics

References

[1] Bommakanti V, Banerjee M, Shah D, et al. An overview of synthesis, characterization, applications and associated adverse effects of bioactive nanoparticles[J/OL]. Environ Res, 2022, 214(Pt 2): 113919. https://pubmed.ncbi.nlm.nih.gov/35863448/. DOI: 10.1016/j.envres.2022.113919.

[2] Mitchell M J, Billingsley M M, Haley R M, et al. Engineering precision nanoparticles for drug delivery[J/OL]. Nat Rev Drug Discov, 2021, 20(2): 101-124. https://pubmed.ncbi.nlm.nih.gov/33277608/. DOI: 10.1038/s41573-020-0090-8.

[3] Karmali P P, Simberg D . Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems[J/OL]. Expert Opin Drug Deliv, 2011, 8(3): 343-357. https://pubmed.ncbi.nlm.nih.gov/21291354/. DOI: 10.1517/17425247.2011.554818.

[4] Zhang Y N, Poon W, Tavares A J, et al. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination[J/OL]. J Control Release, 2016, 240: 332-348. https://pubmed.ncbi.nlm.nih.gov/26774224/. DOI: 10.1016/j.jconrel.2016.01.020.

[5] Nowak-Jary J, Machnicka B . In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications[J/OL]. Int J Nanomedicine, 2023, 18: 4067-4100. https://pubmed.ncbi.nlm.nih.gov/37525695/. DOI: 10.2147/ijn.S415063.

[6] Suk J S, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery[J/OL]. Adv Drug Deliv Rev, 2016, 99(Pt A): 28-51. https://pubmed.ncbi.nlm.nih.gov/26456916/. DOI: 10.1016/j.addr.2015.09.012.

[7] Kozma G T, Shimizu T, Ishida T, et al. Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals[J/OL]. Adv Drug Deliv Rev, 2020, 154-155: 163-175. https://pubmed.ncbi.nlm.nih.gov/32745496/. DOI: 10.1016/j.addr.2020.07.024.

[8] Zhang P, Sun F, Liu S, et al. Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation[J/OL]. J Control Release, 2016, 244(Pt B): 184-193. https://pubmed.ncbi.nlm.nih.gov/27369864/. DOI: 10.1016/j.jconrel.2016.06.040.

[9] Fang R H, Kroll A V, Gao W, et al. Cell Membrane Coating Nanotechnology[J/OL]. Adv Mater, 2018, 30(23): e1706759. https://pubmed.ncbi.nlm.nih.gov/29582476/. DOI: 10.1002/adma.201706759.

[10] Hu C M, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform[J/OL]. Proc Natl Acad Sci U S A, 2011, 108(27): 10980-10985. https://pubmed.ncbi.nlm.nih.gov/21690347/. DOI: 10.1073/pnas.1106634108.

[11] Hu C M, Fang R H, Wang K C, et al. Nanoparticle biointerfacing by platelet membrane cloaking[J/OL]. Nature, 2015, 526(7571): 118-121. https://pubmed.ncbi.nlm.nih.gov/26374997/. DOI: 10.1038/nature15373.

[12] Wang D, Wang S, Zhou Z, et al. White Blood Cell Membrane-Coated Nanoparticles: Recent Development and Medical Applications[J/OL]. Adv Healthc Mater, 2022, 11(7): e2101349. https://pubmed.ncbi.nlm.nih.gov/34468090/. DOI: 10.1002/adhm.202101349.

[13] Guo Q, Wang S, Xu R, et al. Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform[J/OL]. RSC Adv, 2024, 14(15): 10608-10637. https://pubmed.ncbi.nlm.nih.gov/38567339/. DOI: 10.1039/D4RA01026D.

[14] Ferreira-Faria I, Yousefiasl S, Macário-Soares A, et al. Stem cell membrane-coated abiotic nanomaterials for biomedical applications[J/OL]. J Control Release, 2022, 351: 174-197. https://pubmed.ncbi.nlm.nih.gov/36103910/. DOI: 10.1016/j.jconrel.2022.09.012.

[15] Hakimi F, Almasi F, Etezadi H, et al. Engineering biomimetic bacteria membrane-coated nanoparticles: an emerging anti-infection platform[J/OL]. Mater Horiz, 2025, 12(22): 9337-9358. https://pubmed.ncbi.nlm.nih.gov/41078073/. DOI: 10.1039/D5MH00918A.

[16] An Y, Ji C, Zhang H, et al. Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale[J/OL]. ACS Nano, 2025, 19(12): 11517-11546. https://pubmed.ncbi.nlm.nih.gov/40126356/. DOI: 10.1021/acsnano.4c16280.

[17] Zeng S, Tang Q, Xiao M, et al. Cell membrane-coated nanomaterials for cancer therapy[J/OL]. Mater Today Bio, 2023, 20: 100633. https://pubmed.ncbi.nlm.nih.gov/37128288/. DOI: 10.1016/j.mtbio.2023.100633.

[18] Chen O, Zhou Y, Xu Z, et al. Engineered biomembrane-camouflaged nanoparticles: Promising strategies to treat inflammatory skeletal diseases[J/OL]. J Control Release, 2025, 385: 114025. https://pubmed.ncbi.nlm.nih.gov/40651597/. DOI: 10.1016/j.jconrel.2025.114025.

[19] Bi X, Wang Z, He J . Recent advances in biomimetic nanodelivery systems for the treatment of myocardial ischemia reperfusion injury[J/OL]. Colloids Surf B Biointerfaces, 2025, 247: 114414. https://pubmed.ncbi.nlm.nih.gov/39626610/. DOI: 10.1016/j.colsurfb.2024.114414.

[20] Ma J, Jiang L, Liu G . Cell membrane-coated nanoparticles for the treatment of bacterial infection[J/OL]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2022, 14(5): e1825. https://pubmed.ncbi.nlm.nih.gov/35725897/. DOI: 10.1002/wnan.1825.

[21] Peres M A, Macpherson L M D, Weyant R J, et al. Oral diseases: a global public health challenge[J/OL]. Lancet, 2019, 394(10194): 249-260. https://pubmed.ncbi.nlm.nih.gov/31327369/. DOI: 10.1016/s0140-6736(19)31146-8.

[22] Sung H, Ferlay J, Siegel R L, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J/OL]. CA Cancer J Clin, 2021, 71(3): 209-249. https://pubmed.ncbi.nlm.nih.gov/33538338/. DOI: 10.3322/caac.21660.

[23] Barsouk A, Aluru J S, Rawla P, et al. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma[J/OL]. Med Sci (Basel), 2023, 11(2): 42. https://pubmed.ncbi.nlm.nih.gov/37367741/. DOI: 10.3390/medsci11020042.

[24] Nascimento G G, Alves-Costa S, Romandini M . Burden of severe periodontitis and edentulism in 2021, with projections up to 2050: The Global Burden of Disease 2021 study[J/OL]. J Periodontal Res, 2024, 59(5): 823-867. https://pubmed.ncbi.nlm.nih.gov/39192495/. DOI: 10.1111/jre.13337.

[25] Nazir M A . Prevalence of periodontal disease, its association with systemic diseases and prevention[J/OL]. Int J Health Sci (Qassim), 2017, 11(2): 72-80. https://pubmed.ncbi.nlm.nih.gov/28539867/. PMID:28539867.

[26] Liccardo D, Marzano F, Carraturo F, et al. Potential Bidirectional Relationship Between Periodontitis and Alzheimer's Disease[J/OL]. Front Physiol, 2020, 11: 683. https://pubmed.ncbi.nlm.nih.gov/32719612/. DOI: 10.3389/fphys.2020.00683.

[27] Lee S Y, Kim K H . Association of oral disease with cancer incidence and mortality among adults in South Korea: A nationwide retrospective cohort study[J/OL]. Sci Prog, 2025, 108(2): 368504251345632. https://pubmed.ncbi.nlm.nih.gov/40530565/. DOI: 10.1177/00368504251345632.

[28] Baima G, Minoli M, Michaud D S, et al. Periodontitis and risk of cancer: Mechanistic evidence[J/OL]. Periodontol 2000, 2024, 96(1): 83-94. https://pubmed.ncbi.nlm.nih.gov/38102837/. DOI: 10.1111/prd.12540.

[29] Li Z, Yu C, Chen H . Global, regional, and national caries of permanent teeth incidence, prevalence, and disability-adjusted life years, 1990-2021: analysis for the global burden of disease study[J/OL]. BMC Oral Health, 2025, 25(1): 715. https://pubmed.ncbi.nlm.nih.gov/40361035/. DOI: 10.1186/s12903-025-06086-z.

[30] Sun L, He L, Wu W, et al. Fibroblast membrane-camouflaged nanoparticles for inflammation treatment in the early stage[J/OL]. Int J Oral Sci, 2021, 13(1): 39. https://pubmed.ncbi.nlm.nih.gov/34785637/. DOI: 10.1038/s41368-021-00144-2.

[31] Corrons J L V, Casafont L B, Frasnedo E F . Concise review: how do red blood cells born, live, and die?[J/OL]. Ann Hematol, 2021, 100(10): 2425-2433. https://pubmed.ncbi.nlm.nih.gov/34342697/. DOI: 10.1007/s00277-021-04575-z.

[32] Oldenborg P A, Zheleznyak A, Fang Y F, et al. Role of CD47 as a marker of self on red blood cells[J/OL]. Science, 2000, 288(5473): 2051-2054. https://pubmed.ncbi.nlm.nih.gov/10856220/. DOI: 10.1126/science.288.5473.2051.

[33] Barclay A N, Van den Berg T K . The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target[J/OL]. Annu Rev Immunol, 2014, 32: 25-50. https://pubmed.ncbi.nlm.nih.gov/24215318/. DOI: 10.1146/annurev-immunol-032713-120142.

[34] Willingham S B, Volkmer J P, Gentles A J, et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors[J/OL]. Proc Natl Acad Sci U S A, 2012, 109(17): 6662-6667. https://pubmed.ncbi.nlm.nih.gov/22451913/. DOI: 10.1073/pnas.1121623109.

[35] Zhu W, Zhou Y, Guo L, et al. Biological function of sialic acid and sialylation in human health and disease[J/OL]. Cell Death Discov, 2024, 10(1): 415. https://pubmed.ncbi.nlm.nih.gov/39349440/. DOI: 10.1038/s41420-024-02180-3.

[36] Luk B T, Hu C M, Fang R H, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles[J/OL]. Nanoscale, 2014, 6(5): 2730-2737. https://pubmed.ncbi.nlm.nih.gov/24463706/. DOI: 10.1039/c3nr06371b.

[37] Saffioti N A, Lauri N, Cané L, et al. Interactive Dynamics of Cell Volume and Cell Death in Human Erythrocytes Exposed to α-Hemolysin from Escherichia coli[J/OL]. Int J Mol Sci, 2022, 23(2): 872. https://pubmed.ncbi.nlm.nih.gov/35055067/. DOI: 10.3390/ijms23020872.

[38] Wu X, Li Y, Raza F, et al. Red Blood Cell Membrane-Camouflaged Tedizolid Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy[J/OL]. Pharmaceutics, 2021, 13(1): 99. https://pubmed.ncbi.nlm.nih.gov/33466655/. DOI: 10.3390/pharmaceutics13010099.

[39] Liu H, Su Y Y, Jiang X C, et al. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system[J/OL]. Drug Deliv Transl Res, 2023, 13(3): 716-737. https://pubmed.ncbi.nlm.nih.gov/36417162/. DOI: 10.1007/s13346-022-01252-0.

[40] Song M, Dong S, An X, et al. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers[J/OL]. J Control Release, 2022, 345: 744-754. https://pubmed.ncbi.nlm.nih.gov/35381274/. DOI: 10.1016/j.jconrel.2022.03.060.

[41] Zhang L, Wang Z, Zhang Y, et al. Erythrocyte Membrane Cloaked Metal - Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy[J/OL]. ACS Nano, 2018, 12(10): 10201-10211. https://pubmed.ncbi.nlm.nih.gov/30265804/. DOI: 10.1021/acsnano.8b05200.

[42] Ma W, Yang Y, Zhu J, et al. Biomimetic Nanoerythrosome-Coated Aptamer-DNA Tetrahedron/Maytansine Conjugates: pH-Responsive and Targeted Cytotoxicity for HER2-Positive Breast Cancer[J/OL]. Adv Mater, 2022, 34(46): 2109609. https://pubmed.ncbi.nlm.nih.gov/35064993/. DOI: 10.1002/adma.202109609.

[43] Aslam T, Akhtar B, Sharif A, et al. Erythrocyte membrane coated biodegradable nanoparticles detoxify LPS-induced toxicity by producing non-mutagenic metabolites and downregulating pro-inflammatory cytokines and oxidative stress markers[J/OL]. Sci Rep, 2025, 15(1): 33634. https://pubmed.ncbi.nlm.nih.gov/41022808/. DOI: 10.1038/s41598-025-07196-y.

[44] Liang X, Li H, Zhang A, et al. Red blood cell biomimetic nanoparticle with anti-inflammatory, anti-oxidative and hypolipidemia effect ameliorated atherosclerosis therapy[J/OL]. Nanomedicine, 2022, 41: 102519. https://pubmed.ncbi.nlm.nih.gov/35038590/. DOI: 10.1016/j.nano.2022.102519.

[45] Huang K, Wen S, Wang W, et al. Erythrocyte membrane coated nanoparticle-based control releasing hydrogen sulfide system protects ischemic myocardium[J/OL]. Nanomedicine (Lond), 2021, 16(6): 465-480. https://pubmed.ncbi.nlm.nih.gov/33599532/. DOI: 10.2217/nnm-2020-0404.

[46] Escajadillo T, Olson J, Luk B T, et al. A Red Blood Cell Membrane-Camouflaged Nanoparticle Counteracts Streptolysin O-Mediated Virulence Phenotypes of Invasive Group A Streptococcus[J/OL]. Front Pharmacol, 2017, 8: 477. https://pubmed.ncbi.nlm.nih.gov/28769806/. DOI: 10.3389/fphar.2017.00477.

[47] Ding X, Wang H, Liu F, et al. Biomimetic RBC-membrane-cloaked Prussian blue nanoparticles for synergistic photothermal-antibacterial therapy and accelerated wound healing[J/OL]. Mater Des, 2025, 254: 114097. https://www.sciencedirect.com/science/article/pii/S0264127525005179. DOI: 10.1016/j.matdes.2025.114097.

[48] Liu J, Ding H, Zhao M, et al. Functionalized Erythrocyte Membrane-Coated Nanoparticles for the Treatment of Klebsiella pneumoniae-Induced Sepsis[J/OL]. Front Microbiol, 2022, 13: 901979. https://pubmed.ncbi.nlm.nih.gov/35783411/. DOI: 10.3389/fmicb.2022.901979.

[49] Chen L, Jiang X, Liu Q, et al. A dual-targeting near-infrared biomimetic drug delivery system for HBV treatment[J/OL]. J Med Virol, 2023, 95(1): e28312. https://pubmed.ncbi.nlm.nih.gov/36404678/. DOI: 10.1002/jmv.28312.

[50] Chen H W, Fang Z S, Chen Y T, et al. Targeting and Enrichment of Viral Pathogen by Cell Membrane Cloaked Magnetic Nanoparticles for Enhanced Detection[J/OL]. ACS Appl Mater Interfaces, 2017, 9(46): 39953-39961. https://pubmed.ncbi.nlm.nih.gov/29088538/. DOI: 10.1021/acsami.7b09931.

[51] Xiong J, Wu M, Chen J, et al. Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer[J/OL]. ACS Nano, 2021, 15(12): 19756-19770. https://pubmed.ncbi.nlm.nih.gov/34860006/. DOI: 10.1021/acsnano.1c07180.

[52] Jan N, Yehia R M, Mohammed M, et al. Cell membrane-coated nanoparticles: A new frontier in atherosclerosis therapy[J/OL]. Chem Eng J, 2025, 524: 169183. https://www.sciencedirect.com/science/article/abs/pii/S1385894725100260. DOI: 10.1016/j.cej.2025.169183.

[53] Dai Z, Zhao T, Song N, et al. Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects[J/OL]. Front Pharmacol, 2022, 13: 1026386. https://pubmed.ncbi.nlm.nih.gov/36330089/. DOI: 10.3389/fphar.2022.1026386.

[54] Ruiz-Argüelles A, Llorente L . The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias[J/OL]. Autoimmun Rev, 2007, 6(3): 155-161. https://pubmed.ncbi.nlm.nih.gov/17289551/. DOI: 10.1016/j.autrev.2006.09.008.

[55] Li M, Li J, Chen J, et al. Platelet Membrane Biomimetic Magnetic Nanocarriers for Targeted Delivery and in Situ Generation of Nitric Oxide in Early Ischemic Stroke[J/OL]. ACS Nano, 2020, 14(2): 2024-2035. https://pubmed.ncbi.nlm.nih.gov/31927980/. DOI: 10.1021/acsnano.9b08587.

[56] Kieffer N, Phillips D R . Platelet membrane glycoproteins: functions in cellular interactions[J/OL]. Annu Rev Cell Biol, 1990, 6: 329-357. https://pubmed.ncbi.nlm.nih.gov/2275816/. DOI: 10.1146/annurev.cb.06.110190.001553.

[57] Gremmel T, Frelinger A L 3rd, Michelson A D . Platelet Physiology[J/OL]. Semin Thromb Hemost, 2024, 50(8): 1173-1186. https://pubmed.ncbi.nlm.nih.gov/38653463/. DOI: 10.1055/s-0044-1786387.

[58] Anselmo A C, Modery-Pawlowski C L, Menegatti S, et al. Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries[J/OL]. ACS Nano, 2014, 8(11): 11243-11253. https://pubmed.ncbi.nlm.nih.gov/25318048/. DOI: 10.1021/nn503732m.

[59] Franco A T, Corken A, Ware J . Platelets at the interface of thrombosis, inflammation, and cancer[J/OL]. Blood, 2015, 126(5): 582-588. https://pubmed.ncbi.nlm.nih.gov/26109205/. DOI: 10.1182/blood-2014-08-531582.

[60] Li S, Lu Z, Wu S, et al. The dynamic role of platelets in cancer progression and their therapeutic implications[J/OL]. Nat Rev Cancer, 2024, 24(1): 72-87. https://pubmed.ncbi.nlm.nih.gov/38040850/. DOI: 10.1038/s41568-023-00639-6.

[61] Luo X, Cao J, Yu J, et al. Regulating Acidosis and Relieving Hypoxia by Platelet Membrane-Coated Nanoparticle for Enhancing Tumor Chemotherapy[J/OL]. Front Bioeng Biotechnol, 2022, 10: 885105. https://pubmed.ncbi.nlm.nih.gov/35646869/. DOI: 10.3389/fbioe.2022.885105.

[62] Jiang H, Tang C, Wen Y, et al. Enhanced Antitumor Efficacy of Novel Biomimetic Platelet Membrane-Coated Tetrandrine Nanoparticles in Nonsmall Cell Lung Cancer[J/OL]. Mol Pharm, 2023, 20(11): 5463-5475. https://pubmed.ncbi.nlm.nih.gov/37823637/. DOI: 10.1021/acs.molpharmaceut.3c00310.

[63] Bahmani B, Gong H, Luk B T, et al. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors[J/OL]. Nat Commun, 2021, 12(1): 1999. https://pubmed.ncbi.nlm.nih.gov/33790276/. DOI: 10.1038/s41467-021-22311-z.

[64] Fei S, Ma Y, Zhou B, et al. Platelet membrane biomimetic nanoparticle-targeted delivery of TGF-β1 siRNA attenuates renal inflammation and fibrosis[J/OL]. Int J Pharm, 2024, 659: 124261. https://pubmed.ncbi.nlm.nih.gov/38782155/. DOI: 10.1016/j.ijpharm.2024.124261.

[65] Li X, Tang Z, Kuang L, et al. Platelet membrane-coated nanoparticles inhibit platelet activation and neutrophil extracellular traps formation in acute lung injury[J/OL]. J Transl Med, 2025, 23(1): 841. https://pubmed.ncbi.nlm.nih.gov/40713829/. DOI: 10.1186/s12967-025-06649-2.

[66] Kim J K, Uchiyama S, Gong H, et al. Engineered Biomimetic Platelet Membrane-Coated Nanoparticles Block Staphylococcus aureus Cytotoxicity and Protect Against Lethal Systemic Infection[J/OL]. Engineering (Beijing), 2021, 7(8): 1149-1156. https://pubmed.ncbi.nlm.nih.gov/39449819/. DOI: 10.1016/j.eng.2020.09.013.

[67] Huang R, Cai G Q, Li J, et al. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus[J/OL]. J Nanobiotechnology, 2021, 19(1): 229. https://pubmed.ncbi.nlm.nih.gov/34348721/. DOI: 10.1186/s12951-021-00978-2.

[68] Wei X, Ying M, Dehaini D, et al. Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis[J/OL]. ACS Nano, 2018, 12(1): 109-116. https://pubmed.ncbi.nlm.nih.gov/29216423/. DOI: 10.1021/acsnano.7b07720.

[69] Chen L, Zhou Z, Hu C, et al. Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy[J/OL]. Research (Wash D C), 2022, 2022: 9845459. https://pubmed.ncbi.nlm.nih.gov/35118420/. DOI: 10.34133/2022/9845459.

[70] Song Y, Huang Z, Liu X, et al. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE^-/-) mice [J/OL]. Nanomedicine, 2019, 15(1): 13-24. https://pubmed.ncbi.nlm.nih.gov/30171903/. DOI: 10.1016/j.nano.2018.08.002.

[71] Fang R H, Gao W, Zhang L . Targeting drugs to tumours using cell membrane-coated nanoparticles[J/OL]. Nat Rev Clin Oncol, 2023, 20(1): 33-48. https://pubmed.ncbi.nlm.nih.gov/36307534/. DOI: 10.1038/s41571-022-00699-x.

[72] Yan M, Wang Z, Qiu Z, et al. Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy[J/OL]. Biomark Res, 2024, 12(1): 164. https://pubmed.ncbi.nlm.nih.gov/39736771/. DOI: 10.1186/s40364-024-00700-y.

[73] Galassi C, Chan T A, Vitale I, et al. The hallmarks of cancer immune evasion[J/OL]. Cancer Cell, 2024, 42(11): 1825-1863. https://pubmed.ncbi.nlm.nih.gov/39393356/. DOI: 10.1016/j.ccell.2024.09.010.

[74] Bose R J, Paulmurugan R, Moon J, et al. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics[J/OL]. Drug Discov Today, 2018, 23(4): 891-899. https://pubmed.ncbi.nlm.nih.gov/29426004/. DOI: 10.1016/j.drudis.2018.02.001.

[75] Zhu J Y, Zheng D W, Zhang M K, et al. Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes[J/OL]. Nano Lett, 2016, 16(9): 5895-5901. https://pubmed.ncbi.nlm.nih.gov/27513184/. DOI: 10.1021/acs.nanolett.6b02786.

[76] Fang R H, Hu C M, Luk B T, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery[J/OL]. Nano Lett, 2014, 14(4): 2181-2188. https://pubmed.ncbi.nlm.nih.gov/24673373/. DOI: 10.1021/nl500618u.

[77] Fontana F, Shahbazi M A, Liu D, et al. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy[J/OL]. Adv Mater, 2017, 29(7): 1603239. https://pubmed.ncbi.nlm.nih.gov/28009461/. DOI: 10.1002/adma.201603239.

[78] Min H, Wang J, Qi Y, et al. Biomimetic Metal-Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy[J/OL]. Adv Mater, 2019, 31(15): 1808200. https://pubmed.ncbi.nlm.nih.gov/30773718/. DOI: 10.1002/adma.201808200.

[79] Fang H, Gai Y, Wang S, et al. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer[J/OL]. J Nanobiotechnology, 2021, 19(1): 81. https://pubmed.ncbi.nlm.nih.gov/33743740/. DOI: 10.1186/s12951-021-00827-2.

[80] Chen Q, Zhang L, Li L, et al. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer[J/OL]. J Nanobiotechnology, 2021, 19(1): 449. https://pubmed.ncbi.nlm.nih.gov/34952587/. DOI: 10.1186/s12951-021-01202-x.

[81] Ning S, Dai X, Tang W, et al. Cancer cell membrane-coated C-TiO2 hollow nanoshells for combined sonodynamic and hypoxia-activated chemotherapy[J/OL]. Acta Biomater, 2022, 152: 562-574. https://pubmed.ncbi.nlm.nih.gov/36067874/. DOI: 10.1016/j.actbio.2022.08.067.

[82] Li J, Lin C, Zhu Y, et al. Colorectal cancer cell membrane biomimetic ferroferric oxide nanomaterials for homologous bio-imaging and chemotherapy application[J/OL]. Med Oncol, 2023, 40(11): 322. https://pubmed.ncbi.nlm.nih.gov/37801170/. DOI: 10.1007/s12032-023-02175-7.

[83] Sun Y, Zhai W, Liu X, et al. Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma[J/OL]. J Nanobiotechnology, 2020, 18(1): 60. https://pubmed.ncbi.nlm.nih.gov/32299505/. DOI: 10.1186/s12951-020-00617-2.

[84] Shao F, Wu Y, Tian Z, et al. Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy[J/OL]. Biomaterials, 2021, 274: 120869. https://pubmed.ncbi.nlm.nih.gov/33984636/. DOI: 10.1016/j.biomaterials.2021.120869.

[85] Xu C, Liu W, Hu Y, et al. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy[J/OL]. Theranostics, 2020, 10(7): 3325-3339. https://pubmed.ncbi.nlm.nih.gov/32194871/. DOI: 10.7150/thno.41228.

[86] Yu Z, Zhou P, Pan W, et al. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis[J/OL]. Nat Commun, 2018, 9(1): 5044. https://pubmed.ncbi.nlm.nih.gov/30487569/. DOI: 10.1038/s41467-018-07197-8.

[87] Wu M, Mei T, Lin C, et al. Melanoma Cell Membrane Biomimetic Versatile CuS Nanoprobes for Homologous Targeting Photoacoustic Imaging and Photothermal Chemotherapy[J/OL]. ACS Appl Mater Interfaces, 2020, 12(14): 16031-16039. https://pubmed.ncbi.nlm.nih.gov/32186357/. DOI: 10.1021/acsami.9b23177.

[88] Li J, Zhang J, Gao Y, et al. Targeted siRNA Delivery by Bioinspired Cancer Cell Membrane-Coated Nanoparticles with Enhanced Anti-Cancer Immunity[J/OL]. Int J Nanomedicine, 2023, 18: 5961-5982. https://pubmed.ncbi.nlm.nih.gov/37901359/. DOI: 10.2147/ijn.S429036.

[89] Myers T J, Granero-Molto F, Longobardi L, et al. Mesenchymal stem cells at the intersection of cell and gene therapy[J/OL]. Expert Opin Biol Ther, 2010, 10(12): 1663-1679. https://pubmed.ncbi.nlm.nih.gov/21058931/. DOI: 10.1517/14712598.2010.531257.

[90] Maldonado V V, Patel N H, Smith E E, et al. Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy[J/OL]. J Biol Eng, 2023, 17(1): 44. https://pubmed.ncbi.nlm.nih.gov/37434264/. DOI: 10.1186/s13036-023-00361-9.

[91] Herberts C A, Kwa M S, Hermsen H P . Risk factors in the development of stem cell therapy[J/OL]. J Transl Med, 2011, 9: 29. https://pubmed.ncbi.nlm.nih.gov/21418664/. DOI: 10.1186/1479-5876-9-29.

[92] Hmadcha A, Martin-Montalvo A, Gauthier B R, et al. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy[J/OL]. Front Bioeng Biotechnol, 2020, 8: 43. https://pubmed.ncbi.nlm.nih.gov/32117924/. DOI: 10.3389/fbioe.2020.00043.

[93] Deng S, Nie D, Huang Y, et al. A Magnetic-Responsive Biomimetic Nanosystem Coated with Glioma Stem Cell Membranes Effectively Targets and Eliminates Malignant Gliomas[J/OL]. Biomater Res, 2024, 28: 0123. https://pubmed.ncbi.nlm.nih.gov/39735729/. DOI: 10.34133/bmr.0123.

[94] Zhang M, Zhang F, Liu T, et al. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors[J/OL]. Int J Nanomedicine, 2020, 15: 10183-10197. https://pubmed.ncbi.nlm.nih.gov/33363374/. DOI: 10.2147/ijn.S282931.

[95] Gao C, Lin Z, Wu Z, et al. Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy[J/OL]. ACS Appl Mater Interfaces, 2016, 8(50): 34252-34260. https://pubmed.ncbi.nlm.nih.gov/27936561/. DOI: 10.1021/acsami.6b12865.

[96] Taghavi S, Tabasi H, Zahiri M, et al. Surface engineering of hollow gold nanoparticle with mesenchymal stem cell membrane and MUC-1 aptamer for targeted theranostic application against metastatic breast cancer[J/OL]. Eur J Pharm Biopharm, 2023, 187: 76-86. https://pubmed.ncbi.nlm.nih.gov/37100090/. DOI: 10.1016/j.ejpb.2023.04.014.

[97] Jin H, Zhao Y, Yao Y, et al. Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury[J/OL]. Antioxidants (Basel), 2024, 13(3): 282. https://pubmed.ncbi.nlm.nih.gov/38539816/. DOI: 10.3390/antiox13030282.

[98] Lei T, Li C, Liu Y, et al. Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson's Disease[J/OL]. J Nanobiotechnology, 2024, 22(1): 370. https://pubmed.ncbi.nlm.nih.gov/38918856/. DOI: 10.1186/s12951-024-02587-1.

[99] Tian Y, Sun D, Liu N, et al. Biomimetic mesenchymal stem cell membrane-coated nanoparticle delivery of MKP5 inhibits hepatic fibrosis through the IRE/XBP1 pathway[J/OL]. J Nanobiotechnology, 2024, 22(1): 741. https://pubmed.ncbi.nlm.nih.gov/39609656/. DOI: 10.1186/s12951-024-03029-8.

[100] Lu L, Quan L, Li J, et al. Bioengineered stem cell membrane functionalized nanoparticles combine anti-inflammatory and antimicrobial properties for sepsis treatment[J/OL]. J Nanobiotechnology, 2023, 21(1): 170. https://pubmed.ncbi.nlm.nih.gov/37237294/. DOI: 10.1186/s12951-023-01913-3.

[101] Krishnan N, Zhou J, Mohapatra A, et al. Universal Prophylactic Antitumor Vaccination Using Stem Cell Membrane-Coated Nanoparticles[J/OL]. Adv Mater, 2025, 37(14): e2501616. https://pubmed.ncbi.nlm.nih.gov/39989146/. DOI: 10.1002/adma.202501616.

[102] Sha S, Sun C, Gao X, et al. Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer's Disease[J/OL]. ACS Appl Mater Interfaces, 2025, 17(33): 47497-47511. https://pubmed.ncbi.nlm.nih.gov/40768614/. DOI: 10.1021/acsami.5c09843.

[103] Krueger T E G, Thorek D L J, Denmeade S R, et al. Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise[J/OL]. Stem Cells Transl Med, 2018, 7(9): 651-663. https://pubmed.ncbi.nlm.nih.gov/30070053/. DOI: 10.1002/sctm.18-0024.

[104] Mei R, Wan Z, Yang C, et al. Advances and clinical challenges of mesenchymal stem cell therapy[J/OL]. Front Immunol, 2024, 15: 1421854. https://pubmed.ncbi.nlm.nih.gov/39100671/. DOI: 10.3389/fimmu.2024.1421854.

[105] Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization[J/OL]. Trends Immunol, 2004, 25(12): 677-686. https://pubmed.ncbi.nlm.nih.gov/15530839/. DOI: 10.1016/j.it.2004.09.015.

[106] de Oliveira S, Rosowski E E, Huttenlocher A . Neutrophil migration in infection and wound repair: going forward in reverse[J/OL]. Nat Rev Immunol, 2016, 16(6): 378-391. https://pubmed.ncbi.nlm.nih.gov/27231052/. DOI: 10.1038/nri.2016.49.

[107] Arnon T I, Markel G, Mandelboim O . Tumor and viral recognition by natural killer cells receptors[J/OL]. Semin Cancer Biol, 2006, 16(5): 348-358. https://pubmed.ncbi.nlm.nih.gov/16893656/. DOI: 10.1016/j.semcancer.2006.07.005.

[108] Uzhachenko R V, Shanker A . CD8(+) T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity[J/OL]. Front Immunol, 2019, 10: 1906. https://pubmed.ncbi.nlm.nih.gov/31456803/. DOI: 10.3389/fimmu.2019.01906.

[109] Gao C, Huang Q, Liu C, et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines[J/OL]. Nat Commun, 2020, 11(1): 2622. https://pubmed.ncbi.nlm.nih.gov/32528187/. DOI: 10.1038/s41467-020-16439-7.

[110] Li R, He Y, Zhu Y, et al. Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles[J/OL]. Nano Lett, 2019, 19(1): 124-134. https://pubmed.ncbi.nlm.nih.gov/30521345/. DOI: 10.1021/acs.nanolett.8b03439.

[111] Su Y, Wang W, Xiao Q, et al. Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy[J/OL]. Acta Biomater, 2022, 152: 519-531. https://pubmed.ncbi.nlm.nih.gov/36055610/. DOI: 10.1016/j.actbio.2022.08.055.

[112] Wu L, Yuan A, Tian X, et al. Cell-Membrane-Coated Cationic Nanoparticles Disguised as Macrophages for the Prevention and Treatment of Type 2 Diabetes Mellitus[J/OL]. ACS Appl Mater Interfaces, 2022, 14(45): 50499-50506. https://pubmed.ncbi.nlm.nih.gov/36397312/. DOI: 10.1021/acsami.2c12218.

[113] Zhang L, Li R, Chen H, et al. Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer[J/OL]. Int J Nanomedicine, 2017, 12: 2129-2142. https://pubmed.ncbi.nlm.nih.gov/28360520/. DOI: 10.2147/ijn.S126016.

[114] Kang M, Hong J, Jung M, et al. T-Cell-Mimicking Nanoparticles for Cancer Immunotherapy[J/OL]. Adv Mater, 2020, 32(39): e2003368. https://pubmed.ncbi.nlm.nih.gov/32812291/. DOI: 10.1002/adma.202003368.

[115] Zhang C, Zhang L, Wu W, et al. Artificial Super Neutrophils for Inflammation Targeting and HClO Generation against Tumors and Infections[J/OL]. Adv Mater, 2019, 31(19): e1901179. https://pubmed.ncbi.nlm.nih.gov/30924234/. DOI: 10.1002/adma.201901179.

[116] Feng L, Dou C, Xia Y, et al. Neutrophil-like Cell-Membrane-Coated Nanozyme Therapy for Ischemic Brain Damage and Long-Term Neurological Functional Recovery[J/OL]. ACS Nano, 2021, 15(2): 2263-2280. https://pubmed.ncbi.nlm.nih.gov/33426885/. DOI: 10.1021/acsnano.0c07973.

[117] Zhang Q, Dehaini D, Zhang Y, et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis[J/OL]. Nat Nanotechnol, 2018, 13(12): 1182-1190. https://pubmed.ncbi.nlm.nih.gov/30177807/. DOI: 10.1038/s41565-018-0254-4.

[118] Yu G T, Rao L, Wu H, et al. Myeloid-Derived Suppressor Cell Membrane-Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death[J/OL]. Adv Funct Mater, 2018, 28(37): 1801389. https://advanced.onlinelibrary.wiley.com/doi/10.1002/adfm.201801389. DOI: 10.1002/adfm.201801389.

[119] Xiao P, Wang J, Zhao Z, et al. Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy[J/OL]. Nano Lett, 2021, 21(5): 2094-2103. https://pubmed.ncbi.nlm.nih.gov/33622034/. DOI: 10.1021/acs.nanolett.0c04783.

[120] Li Q, Byun J, Kim D, et al. Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy[J/OL]. Asian J Pharm Sci, 2024, 19(6): 100968. https://pubmed.ncbi.nlm.nih.gov/39640052/. DOI: 10.1016/j.ajps.2024.100968.

[121] Deng G, Sun Z, Li S, et al. Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth[J/OL]. ACS Nano, 2018, 12(12): 12096-12108. https://pubmed.ncbi.nlm.nih.gov/30444351/. DOI: 10.1021/acsnano.8b05292.

[122] Pitchaimani A, Nguyen T D T, Aryal S . Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy[J/OL]. Biomaterials, 2018, 160: 124-137. https://pubmed.ncbi.nlm.nih.gov/29407341/. DOI: 10.1016/j.biomaterials.2018.01.018.

[123] Ozsoy F, Mohammed M, Jan N, et al. T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies[J/OL]. ACS Appl Bio Mater, 2024, 7(5): 2637-2659. https://pubmed.ncbi.nlm.nih.gov/38687958/. DOI: 10.1021/acsabm.4c00074.

[124] Liu Y, Luo J, Chen X, et al. Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications[J/OL]. Nanomicro Lett, 2019, 11(1): 100. https://pubmed.ncbi.nlm.nih.gov/34138027/. DOI: 10.1007/s40820-019-0330-9.

[125] Waller T, Kesper L, Hirschfeld J, et al. Porphyromonas gingivalis Outer Membrane Vesicles Induce Selective Tumor Necrosis Factor Tolerance in a Toll-Like Receptor 4-and mTOR-Dependent Manner [J/OL]. Infect Immun, 2016, 84(4): 1194-1204. https://pubmed.ncbi.nlm.nih.gov/26857578/. DOI: 10.1128/iai.01390-15.

[126] Chen Q, Liu C, Liu C, et al. Wrapping Porphyromonas gingivalis for tumor microenvironment immunomodulation and photothermal immunotherapy[J/OL]. Nano Today, 2021, 41: 101311. https://www.sciencedirect.com/science/article/abs/pii/S174801322100236X. DOI: 10.1016/j.nantod.2021.101311.

[127] Dou J, Chen X, Zhang J, et al. P. Gingivalis induce macrophage polarization by regulating hepcidin expression in chronic apical periodontitis [J/OL]. Int Immunopharmacol, 2024, 142: 113139. https://pubmed.ncbi.nlm.nih.gov/39278061/. DOI: 10.1016/j.intimp.2024.113139.

[128] Patel R B, Ye M, Carlson P M, et al. Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial-Membrane-Coated Nanoparticles[J/OL]. Adv Mater, 2019, 31(43): e1902626. https://pubmed.ncbi.nlm.nih.gov/31523868/. DOI: 10.1002/adma.201902626.

[129] Ye S, Liu J, Huang S, et al. Coated nanoparticles enhance immune efficacy of Helicobacter pylori outer membrane vesicles by activating Th1/Th2/Th17 responses [J/OL]. J Pharmacol Exp Ther, 2025, 392(9): 103669. https://pubmed.ncbi.nlm.nih.gov/40829202/. DOI: 10.1016/j.jpet.2025.103669.

[130] Bjånes E, Krishnan N, Koh T, et al. STING-adjuvanted outer membrane vesicle nanoparticle vaccine against Pseudomonas aeruginosa [J/OL]. JCI Insight, 2025, 10(17): e188105. https://pubmed.ncbi.nlm.nih.gov/40705476/. DOI: 10.1172/jci.insight.188105.

[131] Bjanes E, Zhou J, Qayum T, et al. Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects Against Acinetobacter baumannii Pneumonia and Sepsis [J/OL]. Adv Nanobiomed Res, 2023, 3(2): 2200130. https://pubmed.ncbi.nlm.nih.gov/37151210/. DOI: 10.1002/anbr.202200130.

[132] Gao W, Fang R H, Thamphiwatana S, et al. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles[J/OL]. Nano Lett, 2015, 15(2): 1403-1409. https://pubmed.ncbi.nlm.nih.gov/25615236/. DOI: 10.1021/nl504798g.

[133] Wu S, Huang Y, Yan J, et al. Bacterial Outer Membrane-Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram-Negative Bacterial Infection In Vivo[J/OL]. Adv Funct Mater, 2021, 31(35): 2103442. https://advanced.onlinelibrary.wiley.com/doi/10.1002/adfm.202103442. DOI: 10.1002/adfm.202103442.

[134] Weng L, Wu L, Guo R, et al. Lactobacillus cell envelope-coated nanoparticles for antibiotic delivery against cariogenic biofilm and dental caries[J/OL]. J Nanobiotechnology, 2022, 20(1): 356. https://pubmed.ncbi.nlm.nih.gov/35918726/. DOI: 10.1186/s12951-022-01563-x.

[135] Chandler CE, Ernst RK . Bacterial lipids: powerful modifiers of the innate immune response[J/OL]. F1000Res, 2017, 6: F1000 Faculty Rev-1334. https://pubmed.ncbi.nlm.nih.gov/28868130/. DOI: 10.12688/f1000research.11388.1.

[136] Rao L, Bu L L, Xu J H, et al. Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance[J/OL]. Small, 2015, 11(46): 6225-6236. https://pubmed.ncbi.nlm.nih.gov/26488923/. DOI: 10.1002/smll.201502388.

[137] Li J, Ai Y, Wang L, et al. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles[J/OL]. Biomaterials, 2016, 76: 52-65. https://pubmed.ncbi.nlm.nih.gov/26519648/. DOI: 10.1016/j.biomaterials.2015.10.046.

[138] Nie D, Dai Z, Li J, et al. Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk-Shell Structure Augment Cancer Chemotherapy[J/OL]. Nano Lett, 2020, 20(2): 936-946. https://pubmed.ncbi.nlm.nih.gov/31671946/. DOI: 10.1021/acs.nanolett.9b03817.

[139] Park J H, Jiang Y, Zhou J, et al. Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs[J/OL]. Sci Adv, 2021, 7(25): eabf7820. https://pubmed.ncbi.nlm.nih.gov/34134990/. DOI: 10.1126/sciadv.abf7820.

[140] Van Hee P, Middelberg A P, Van Der Lans R G, et al. Relation between cell disruption conditions, cell debris particle size, and inclusion body release[J/OL]. Biotechnol Bioeng, 2004, 88(1): 100-110. https://pubmed.ncbi.nlm.nih.gov/15449302/. DOI: 10.1002/bit.20343.

[141] Chugh V, Vijaya Krishna K, Pandit A . Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation[J/OL]. ACS Nano, 2021, 15(11): 17080-17123. https://pubmed.ncbi.nlm.nih.gov/34699181/. DOI: 10.1021/acsnano.1c03800.

[142] Joudeh N, Linke D . Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists[J/OL]. J Nanobiotechnology, 2022, 20(1): 262. https://pubmed.ncbi.nlm.nih.gov/35672712/. DOI: 10.1186/s12951-022-01477-8.

[143] Su Y, Zhang B, Sun R, et al. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application[J/OL]. Drug Deliv, 2021, 28(1): 1397-1418. https://pubmed.ncbi.nlm.nih.gov/34184949/. DOI: 10.1080/10717544.2021.1938756.

[144] John R, Monpara J, Swaminathan S, et al. Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up[J/OL]. Pharmaceutics, 2024, 16(1): 131. https://pubmed.ncbi.nlm.nih.gov/38276502/. DOI: 10.3390/pharmaceutics16010131.

[145] Bu L L, Rao L, Yu G T, et al. Cancer Stem Cell-Platelet Hybrid Membrane-Coated Magnetic Nanoparticles for Enhanced Photothermal Therapy of Head and Neck Squamous Cell Carcinoma[J/OL]. Adv Funct Mater, 2019, 29(10): 1807733. https://advanced.onlinelibrary.wiley.com/doi/10.1002/adfm.201807733. DOI: 10.1002/adfm.201807733.

[146] Elahi N, Kamali M, Baghersad M H . Recent biomedical applications of gold nanoparticles: A review[J/OL]. Talanta, 2018, 184: 537-556. https://pubmed.ncbi.nlm.nih.gov/29674080/. DOI: 10.1016/j.talanta.2018.02.088.

[147] Vallet-Regí M, Colilla M, Izquierdo-Barba I, et al. Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights[J/OL]. Molecules, 2017, 23(1): 47. https://pubmed.ncbi.nlm.nih.gov/29295564/. DOI: 10.3390/molecules23010047.

[148] Yang J, Yang Y W . Metal-Organic Frameworks for Biomedical Applications[J/OL]. Small, 2020, 16(10): 1906846. https://pubmed.ncbi.nlm.nih.gov/32026590/. DOI: 10.1002/smll.201906846.

[149] Sahu K P, Singh S, Singh A K, et al. Nanomaterials via ZIF-8: Preparations, catalytic and drug delivery applications[J/OL]. Chem Eng J, 2025, 508: 160663. https://www.sciencedirect.com/science/article/abs/pii/S1385894725014846. DOI: 10.1016/j.cej.2025.160663.

[150] Oroojalian F, Beygi M, Baradaran B, et al. Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy[J/OL]. Small, 2021, 17(12): e2006484. https://pubmed.ncbi.nlm.nih.gov/33577127/. DOI: 10.1002/smll.202006484.

[151] Arrigo R, Teresi R, Gambarotti C, et al. Sonication-Induced Modification of Carbon Nanotubes: Effect on the Rheological and Thermo-Oxidative Behaviour of Polymer-Based Nanocomposites[J/OL]. Materials (Basel), 2018, 11(3): 383. https://pubmed.ncbi.nlm.nih.gov/29510595/. DOI: 10.3390/ma11030383.

[152] Rao L, Cai B, Bu L L, et al. Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy[J/OL]. ACS Nano, 2017, 11(4): 3496-3505. https://pubmed.ncbi.nlm.nih.gov/28272874/. DOI: 10.1021/acsnano.7b00133.

[153] Ma J, Ding L, Peng X, et al. Recent Advances of Engineered Cell Membrane-Based Nanotherapeutics to Combat Inflammatory Diseases[J/OL]. Small, 2024, 20(28): e2308646. https://pubmed.ncbi.nlm.nih.gov/38334202/. DOI: 10.1002/smll.202308646.

[154] Yan H, Shao D, Lao Y H, et al. Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation[J/OL]. Adv Sci (Weinh), 2019, 6(15): 1900605. https://pubmed.ncbi.nlm.nih.gov/31406672/. DOI: 10.1002/advs.201900605.

[155] Fu S, Liang M, Wang Y, et al. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma[J/OL]. ACS Appl Mater Interfaces, 2019, 11(2): 1841-1854. https://pubmed.ncbi.nlm.nih.gov/30582685/. DOI: 10.1021/acsami.8b18664.

[156] Chai Z, Ran D, Lu L, et al. Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma[J/OL]. ACS Nano, 2019, 13(5): 5591-5601. https://pubmed.ncbi.nlm.nih.gov/31070352/. DOI: 10.1021/acsnano.9b00661.

[157] Lv W, Xu J, Wang X, et al. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment[J/OL]. ACS Nano, 2018, 12(6): 5417-5426. https://pubmed.ncbi.nlm.nih.gov/29869497/. DOI: 10.1021/acsnano.8b00477.

[158] Zhang Q, Zhou J, Zhou J, et al. Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis[J/OL]. Nat Commun, 2021, 12(1): 4136. https://pubmed.ncbi.nlm.nih.gov/34230486/. DOI: 10.1038/s41467-021-24447-4.

[159] Zhang M, Cheng S, Jin Y, et al. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics[J/OL]. Clin Transl Med, 2021, 11(2): e292. https://pubmed.ncbi.nlm.nih.gov/33635002/. DOI: 10.1002/ctm2.292.

[160] Li P Y, Fan Z, Cheng H . Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy[J/OL]. Bioconjug Chem, 2018, 29(3): 624-634. https://pubmed.ncbi.nlm.nih.gov/29323870/. DOI: 10.1021/acs.bioconjchem.7b00669.

[161] Zhou H, Fan Z, Lemons P K, et al. A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles[J/OL]. Theranostics, 2016, 6(7): 1012-1022. https://pubmed.ncbi.nlm.nih.gov/27217834/. DOI: 10.7150/thno.15095.

[162] Zhang Q, Wei W, Wang P, et al. Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy[J/OL]. ACS Nano, 2017, 11(11): 10724-10732. https://pubmed.ncbi.nlm.nih.gov/28921946/. DOI: 10.1021/acsnano.7b04955.

[163] Teo K Y W, Sevencan C, Cheow Y A, et al. Macrophage Polarization as a Facile Strategy to Enhance Efficacy of Macrophage Membrane-Coated Nanoparticles in Osteoarthritis[J/OL]. Small Sci, 2022, 2(4): 2100116. https://pubmed.ncbi.nlm.nih.gov/40212669/. DOI: 10.1002/smsc.202100116.

[164] Wang C, Wang Y, Zhang L, et al. Pretreated Macrophage-Membrane-Coated Gold Nanocages for Precise Drug Delivery for Treatment of Bacterial Infections[J/OL]. Adv Mater, 2018, 30(46): e1804023. https://pubmed.ncbi.nlm.nih.gov/30285289/. DOI: 10.1002/adma.201804023.

[165] Ou Z, Zhong H, Zhang L, et al. Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing Endotoxin[J/OL]. Int J Nanomedicine, 2020, 15: 4125-4138. https://pubmed.ncbi.nlm.nih.gov/32606668/. DOI: 10.2147/ijn.S253125.

[166] Lin S, Xu Z, Liu Y, et al. Engineered Macrophage Membrane-Camouflaged Nanodecoys Reshape the Infectious Microenvironment for Efficient Periodontitis Treatment[J/OL]. ACS Nano, 2025, 19(16): 15345-15362. https://pubmed.ncbi.nlm.nih.gov/40228155/. DOI: 10.1021/acsnano.4c14305.

[167] He H, Guo C, Wang J, et al. Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing[J/OL]. Nano Lett, 2018, 18(10): 6164-6174. https://pubmed.ncbi.nlm.nih.gov/30207473/. DOI: 10.1021/acs.nanolett.8b01892.

[168] Dehaini D, Wei X, Fang R H, et al. Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization[J/OL]. Adv Mater, 2017, 29(16): 1606209. https://pubmed.ncbi.nlm.nih.gov/28199033/. DOI: 10.1002/adma.201606209.

[169] Esteban-Fernández de Ávila B, Angsantikul P, Ramírez-Herrera D E, et al. Hybrid biomembrane-functionalized nanorobots for concurrent removal of pathogenic bacteria and toxins[J/OL]. Science Robotics, 2018, 3(18): eaat0485. https://pubmed.ncbi.nlm.nih.gov/33141704/. DOI: 10.1126/scirobotics.aat0485.

[170] Makvandi P, Josic U, Delfi M, et al. Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management[J/OL]. Adv Sci (Weinh), 2021, 8(8): 2004014. https://pubmed.ncbi.nlm.nih.gov/33898183/. DOI: 10.1002/advs.202004014.

[171] Knop K, Hoogenboom R, Fischer D, et al. Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives[J/OL]. Angew Chem Int Ed Engl, 2010, 49(36): 6288-6308. https://pubmed.ncbi.nlm.nih.gov/20648499/. DOI: 10.1002/anie.200902672.

[172] Large D E, Abdelmessih R G, Fink E A, et al. Liposome composition in drug delivery design, synthesis, characterization, and clinical application[J/OL]. Adv Drug Deliv Rev, 2021, 176: 113851. https://pubmed.ncbi.nlm.nih.gov/34224787/. DOI: 10.1016/j.addr.2021.113851.

[173] Huang Z-g, Lv F-m, Wang J, et al. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability[J/OL]. Int J Pharm, 2019, 556: 217-225. https://pubmed.ncbi.nlm.nih.gov/30557679/. DOI: 10.1016/j.ijpharm.2018.12.023.

[174] Zhao J, Du J, Wang J, et al. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability[J/OL]. ACS Appl Mater Interfaces, 2021, 13(12): 14577-14586. https://pubmed.ncbi.nlm.nih.gov/33728919/. DOI: 10.1021/acsami.1c00184.

[175] Wang Z, Liu Z, Wang S, et al. Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis[J/OL]. Asian J Pharm Sci, 2023, 18(3): 100800. https://pubmed.ncbi.nlm.nih.gov/37274924/. DOI: 10.1016/j.ajps.2023.100800.

[176] Cui D, Kong N, Yang W, et al. Recent advances in nanoarchitectonics of two-dimensional nanomaterials for dental biosensing and drug delivery[J/OL]. Adv Colloid Interface Sci, 2025, 337: 103388. https://www.sciencedirect.com/science/article/abs/pii/S0001868624003117. DOI: 10.1016/j.cis.2024.103388.

[177] Jia B, Zhang B, Li J, et al. Emerging polymeric materials for treatment of oral diseases: design strategy towards a unique oral environment[J/OL]. Chem Soc Rev, 2024, 53(7): 3273-3301. https://pubmed.ncbi.nlm.nih.gov/38507263/. DOI: 10.1039/D3CS01039B.

[178] Desai N, Tambe V, Pofali P, et al. Cell Membrane-Coated Nanoparticles: A New Frontier in Immunomodulation[J/OL]. Adv Nanobiomed Res, 2024, 4(8): 2400012. https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202400012. DOI: 10.1002/anbr.202400012.

[179] Ye J, Liang W, Wu L, et al. Antimicrobial effect of Streptococcus salivarius outer membrane-coated nanocomplexes against Candida albicans and oral candidiasis[J/OL]. Mater Des, 2023, 233: 112177. https://www.sciencedirect.com/science/article/pii/S0264127523005920. DOI: 10.1016/j.matdes.2023.112177.

[180] Kimiz-Gebologlu I, Oncel S S . Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake[J/OL]. J Control Release, 2022, 347: 533-543. https://pubmed.ncbi.nlm.nih.gov/35597405/. DOI: 10.1016/j.jconrel.2022.05.027.

[181] Overchuk M, Weersink R A, Wilson B C, et al. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine[J/OL]. ACS Nano, 2023, 17(9): 7979-8003. https://pubmed.ncbi.nlm.nih.gov/37129253/. DOI: 10.1021/acsnano.3c00891.

[182] Sun Q, Wu J, Jin L, et al. Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer[J/OL]. J Mater Chem B, 2020, 8(32): 7253-7263. https://pubmed.ncbi.nlm.nih.gov/32638824/. DOI: 10.1039/d0tb01063d.

[183] Wu Q, Ning H, Wang H, et al. Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma[J/OL]. J Drug Target, 2023, 31(5): 511-520. https://pubmed.ncbi.nlm.nih.gov/37000919/. DOI: 10.1080/1061186x.2023.2198172.

[184] Zhou Y, Fan S, Feng L, et al. Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy[J/OL]. Adv Mater, 2021, 33(48): e2104223. https://pubmed.ncbi.nlm.nih.gov/34580933/. DOI: 10.1002/adma.202104223.

[185] Xu H, Zheng C, Zhang Z, et al. Tumor microenvironment-activatable nanocatalysts with chemodynamic therapy and enhanced autophagy for specific treatment of oral squamous cell carcinoma[J/OL]. Colloids Surf B Biointerfaces, 2024, 236: 113713. https://pubmed.ncbi.nlm.nih.gov/38422665/. DOI: 10.1016/j.colsurfb.2023.113713.

[186] Shi S, Fu K, Hou S, et al. Cancer Cell Membrane-Coated Nanoparticles for Treatment of Oral Tongue Squamous Cell Carcinoma by Combining Photothermal/Photodynamic Therapy and Autophagy Inhibition[J/OL]. ACS Appl Nano Mater, 2024, 7(8): 8988-9001. https://pubs.acs.org/doi/10.1021/acsanm.4c00421. DOI: 10.1021/acsanm.4c00421.

[187] Chen J, Zhu Z, Pan Q, et al. Targeted Therapy of Oral Squamous Cell Carcinoma with Cancer Cell Membrane Coated Co-Fc Nanoparticles Via Autophagy Inhibition[J/OL]. Adv Funct Mater, 2023, 33(24): 2300235. https://advanced.onlinelibrary.wiley.com/doi/10.1002/adfm.202300235. DOI: 10.1002/adfm.202300235.

[188] Li H, Zhu L, Zhang Y, et al. Biomimetic nanotherapeutics for homotypic-targeting photothermal/chemotherapy of oral cancer[J/OL]. J Control Release, 2024, 366: 28-43. https://pubmed.ncbi.nlm.nih.gov/38151121/. DOI: 10.1016/j.jconrel.2023.12.039.

[189] Yin Q, Zhang J, Zhang H, et al. Cascade Nanoreactor Employs Mitochondrial-Directed Chemodynamic and δ-ALA-Mediated Photodynamic Synergy for Deep-Seated Oral Cancer Therapy[J/OL]. Adv Healthc Mater, 2024, 13(19): e2304639. https://pubmed.ncbi.nlm.nih.gov/38642071/. DOI: 10.1002/adhm.202304639.

[190] Wu Y, Chang X, Yang G, et al. A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis-Targeting Chimeras Enhanced Immunotherapy[J/OL]. Adv Mater, 2023, 35(12): e2210787. https://pubmed.ncbi.nlm.nih.gov/36656993/. DOI: 10.1002/adma.202210787.

[191] Yu L, Zhu G, Zhang Z, et al. Nano-Photosensitizer Directed Targeted Phototherapy Effective Against Oral Cancer in Animal Model[J/OL]. Int J Nanomedicine, 2023, 18: 6185-6198. https://pubmed.ncbi.nlm.nih.gov/37933297/. DOI: 10.2147/ijn.S434917.

[192] Zhou D, Chen Y, Bu W, et al. Modification of Metal-Organic Framework Nanoparticles Using Dental Pulp Mesenchymal Stem Cell Membranes to Target Oral Squamous Cell Carcinoma[J/OL]. J Colloid Interface Sci, 2021, 601: 650-660. https://pubmed.ncbi.nlm.nih.gov/34091312/. DOI: 10.1016/j.jcis.2021.05.126.

[193] Chen Q, Shan T, Liang Y, et al. A biomimetic phototherapeutic nanoagent based on bacterial double-layered membrane vesicles for comprehensive treatment of oral squamous cell carcinoma[J/OL]. J Mater Chem B, 2023, 11(47): 11265-11279. https://pubmed.ncbi.nlm.nih.gov/37974456/. DOI: 10.1039/d3tb02046k.

[194] Chen H, Deng J, Yao X, et al. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC[J/OL]. J Nanobiotechnology, 2021, 19(1): 342. https://pubmed.ncbi.nlm.nih.gov/34702291/. DOI: 10.1186/s12951-021-01088-9.

[195] Wu Q, Chen L, Huang X, et al. A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft models[J/OL]. Int J Oral Sci, 2023, 15(1): 9. https://pubmed.ncbi.nlm.nih.gov/36765028/. DOI: 10.1038/s41368-022-00211-2.

[196] Zhu X, Chen J, Liao J, et al. Functionalized Multichannel Fluorescence-Encoded Nanosystem on Erythrocyte-Coated Nanoparticles for Precise Cancer Subtype Discrimination[J/OL]. Nano Lett, 2025, 25(1): 426-433. https://pubmed.ncbi.nlm.nih.gov/39690886/. DOI: 10.1021/acs.nanolett.4c05208.

[197] Yan N, Xu J, Liu G, et al. Penetrating Macrophage-Based Nanoformulation for Periodontitis Treatment[J/OL]. ACS Nano, 2022, 16(11): 18253-18265. https://pubmed.ncbi.nlm.nih.gov/36288552/. DOI: 10.1021/acsnano.2c05923.

[198] Guo S, Gu J, Jiang Y, et al. Pretreatment of macrophage-membrane-coated nanoparticles for therapeutical targeting of P. gingivalis-accelerated atherosclerosis[J/OL]. Mater Des, 2022, 223: 111155. https://www.sciencedirect.com/science/article/pii/S0264127522007778. DOI: 10.1016/j.matdes.2022.111155.

[199] Deng Y, Ren M, He P, et al. Genetically engineered cell membrane-coated nanoparticles for antibacterial and immunoregulatory dual-function treatment of ligature-induced periodontitis[J/OL]. Front Bioeng Biotechnol, 2023, 11: 1113367. https://pubmed.ncbi.nlm.nih.gov/36761293/. DOI: 10.3389/fbioe.2023.1113367.

[200] Li S, Wang L, Gu Y, et al. Biomimetic immunomodulation by crosstalk with nanoparticulate regulatory T cells[J/OL]. Matter, 2021, 4(11): 3621-3645. https://www.cell.com/matter/fulltext/S2590-2385%2821%2900409-4. DOI: 10.1016/j.matt.2021.08.015.

[201] Zhao Y Y, Meng Q F, Cui H, et al. Injectable cellular vesicle-based bone meal for inflammatory bone defect repair through restoring immune homeostasis[J/OL]. Theranostics, 2025, 15(10): 4465-4480. https://www.thno.org/v15p4465.htm. DOI: 10.7150/thno.110795.

[202] Cao Q, Xiao X, Tao C, et al. Efficient clearance of periodontitis pathogens by S. gordonii membrane-coated H₂O₂ self-supplied nanocomposites in a "Jenga" style [J/OL]. Biomater Sci, 2023, 11(16): 5680-5693. https://pubmed.ncbi.nlm.nih.gov/37439322/. DOI: 10.1039/d3bm00641g.

[203] Wielento A, Lagosz-Cwik K B, Potempa J, et al. The Role of Gingival Fibroblasts in the Pathogenesis of Periodontitis[J/OL]. J Dent Res, 2023, 102(5): 489-496. https://pubmed.ncbi.nlm.nih.gov/36883660/. DOI: 10.1177/00220345231151921.

[204] Pan S, Zhong W, Lan Y, et al. Pathology-Guided Cell Membrane-Coated Polydopamine Nanoparticles for Efficient Multisynergistic Treatment of Periodontitis[J/OL]. Adv Funct Mater, 2024, 34(23): 2312253. https://advanced.onlinelibrary.wiley.com/doi/10.1002/adfm.202312253. DOI: 10.1002/adfm.202312253.

[205] Wasfi R, Abd El-Rahman O A, Zafer M M, et al. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans [J/OL]. J Cell Mol Med, 2018, 22(3): 1972-1983. https://pubmed.ncbi.nlm.nih.gov/29316223/. DOI: 10.1111/jcmm.13496.

[206] Vila T, Sultan A S, Montelongo-Jauregui D, et al. Oral Candidiasis: A Disease of Opportunity[J/OL]. J Fungi (Basel), 2020, 6(1): 15. https://pubmed.ncbi.nlm.nih.gov/31963180/. DOI: 10.3390/jof6010015.

[207] Ishijima S A, Hayama K, Burton J P, et al. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model [J/OL]. Appl Environ Microbiol, 2012, 78(7): 2190-2199. https://pubmed.ncbi.nlm.nih.gov/22267663/. DOI: 10.1128/aem.07055-11.

[208] Evangelopoulos M, Parodi A, Martinez J O, et al. Cell source determines the immunological impact of biomimetic nanoparticles[J/OL]. Biomaterials, 2016, 82: 168-177. https://pubmed.ncbi.nlm.nih.gov/26761780/. DOI: 10.1016/j.biomaterials.2015.11.054.

[209] Szczepiorkowski Z M, Dunbar N M . Transfusion guidelines: when to transfuse[J/OL]. Hematology Am Soc Hematol Educ Program, 2013, 2013: 638-644. https://pubmed.ncbi.nlm.nih.gov/24319244/. DOI: 10.1182/asheducation-2013.1.638.

[210] Malhotra S, Dumoga S, Singh N . Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation[J/OL]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2022, 14(3): e1776. https://pubmed.ncbi.nlm.nih.gov/35106966/. DOI: 10.1002/wnan.1776.

[211] Tikhonov A, Kachanov A, Yudaeva A, et al. Biomimetic Nanoparticles for Basic Drug Delivery[J/OL]. Pharmaceutics, 2024, 16(10): 1306. https://pubmed.ncbi.nlm.nih.gov/39458635/. DOI: 10.3390/pharmaceutics16101306.

[212] Gornalusse G G, Hirata R K, Funk S E, et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells[J/OL]. Nature Biotechnology, 2017, 35(8): 765-772. https://pubmed.ncbi.nlm.nih.gov/28504668/. DOI: 10.1038/nbt.3860.

[213] Bera R, Pathak S, Srivastava P, et al. Biomimetic nanocarriers for the therapy and management of intestinal inflammations[J/OL]. Int J Pharm X, 2025, 10: 100377. https://pubmed.ncbi.nlm.nih.gov/40919375/. DOI: 10.1016/j.ijpx.2025.100377.

[214] Thakur N, Kumar T, Singh C, et al. Cell membrane-coated nanoparticles for neurodegenerative disorders management[J/OL]. Int J Pharm, 2025, 681: 125875. https://pubmed.ncbi.nlm.nih.gov/40544973/. DOI: 10.1016/j.ijpharm.2025.125875.

[215] Liu L, Bai X, Martikainen M V, et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles[J/OL]. Nat Commun, 2021, 12(1): 5726. https://pubmed.ncbi.nlm.nih.gov/34593813/. DOI: 10.1038/s41467-021-26052-x.

[216] Sultana P, Kim Y K, Cho S J, et al. Advances in cell membrane-coated nanoparticles: multifunctional platforms for targeted drug delivery, precision phototherapy, and enhanced immunotherapy[J/OL]. Biomater Sci, 2025, 13(19): 5232-5259. https://pubmed.ncbi.nlm.nih.gov/40709463/. DOI: 10.1039/D5BM00660K.

[217] Yuan S, Hu D, Gao D, et al. Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier[J/OL]. J Nanobiotechnology, 2025, 23(1): 493. https://pubmed.ncbi.nlm.nih.gov/40624508/. DOI: 10.1186/s12951-025-03572-y.

[218] Jan N, Madni A, Khan S, et al. Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications[J/OL]. Bioeng Transl Med, 2023, 8(2): e10441. https://pubmed.ncbi.nlm.nih.gov/36925703/. DOI: 10.1002/btm2.10441.

[219] Huang L L, Nie W, Zhang J, et al. Cell-Membrane-Based Biomimetic Systems with Bioorthogonal Functionalities[J/OL]. Acc Chem Res, 2020, 53(1): 276-287. https://pubmed.ncbi.nlm.nih.gov/31913016/. DOI: 10.1021/acs.accounts.9b00559.

[220] Yu Y B, Liu Y, Liang H, et al. A Nanoparticle-Based Anticaries Vaccine Enhances the Persistent Immune Response To Inhibit Streptococcus mutans and Prevent Caries[J/OL]. Microbiology Spectrum, 2023, 11(2): e04328-22. https://pubmed.ncbi.nlm.nih.gov/36976019/. DOI: 10.1128/spectrum.04328-22.

[221] Hooshiar M H, Moghaddam M A, Kiarashi M, et al. Recent advances in nanomaterial-based biosensor for periodontitis detection[J/OL]. J Biol Eng, 2024, 18(1): 28. https://pubmed.ncbi.nlm.nih.gov/38637787/. DOI: 10.1186/s13036-024-00423-6.